Swine interferon-inducible transmembrane proteins potently inhibit influenza A virus replication

Journal of Virology

Volumn 89, Issue 1, 2015, Pages 863-869

  Lanz, Caroline ^a   Yángüez, Emilio ^a   Andenmatten, Dario ^a   Stertz, Silke ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN INTERFERON INDUCIBLE TRANSMEMBRANE PROTEIN; IFTM1 LIKE PROTEIN; IFTM2; IFTM3; INTERFERON; MEMBRANE PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; ENDOSOME; GENE SILENCING; HUMAN; HUMAN CELL; INFLUENZA VIRUS A; MOLECULAR CLONING; NONHUMAN; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; SEQUENCE HOMOLOGY; SWINE; VIRUS INHIBITION; VIRUS REPLICATION; ZOONOSIS; ANIMAL; CELL LINE; CHEMISTRY; IMMUNOLOGY; INFLUENZA A VIRUS; PHYSIOLOGY; PIG;

INFLUENZA A VIRUS; SUIDAE; SUS;

ANIMALS; CELL LINE; ENDOSOMES; INFLUENZA A VIRUS; INTERFERONS; MEMBRANE PROTEINS; SWINE; VIRUS REPLICATION;

EID: 84919418051     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02516-14     Document Type: Article

References (24)

1. Brass AL, Huang IC, Benita Y, John SP, Krishnan MN, Feeley EM, Ryan BJ, Weyer JL, van der Weyden L, Fikrig E, Adams DJ, Xavier RJ, Farzan M, Elledge SJ. 2009. The IFITM proteins mediate cellular resistance to influenzaAH1N1 virus, West Nile virus, and dengue virus. Cell 139:1243-1254. http://dx.doi.org/10.1016/j.cell.2009.12.017.
2. Mudhasani R, Tran JP, Retterer C, Radoshitzky SR, Kota KP, Altamura LA, Smith JM, Packard BZ, Kuhn JH, Costantino J, Garrison AR, Schmaljohn CS, Huang IC, Farzan M, Bavari S. 2013. IFITM-2 and IFITM-3 but not IFITM-1 restrict Rift Valley fever virus. J Virol 87:8451-8464. http://dx.doi.org/10.1128/JVI.03382-12.
3. Huang IC, Bailey CC, Weyer JL, Radoshitzky SR, Becker MM, Chiang JJ, Brass AL, Ahmed AA, Chi X, Dong L, Longobardi LE, Boltz D, Kuhn J H, Elledge SJ, Bavari S, Denison MR, Choe H, Farzan M. 2011. Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus. PLoS Pathog 7:e1001258. http://dx.doi.org/10.1371/journal.ppat.1001258.
4. Anafu AA, Bowen CH, Chin CR, Brass AL, Holm GH. 2013. Interferoninducible transmembrane protein 3 (IFITM3) restricts reovirus cell entry. J Biol Chem 288:17261-17271. http://dx.doi.org/10.1074/jbc.M112.438515.
5. Lu J, Pan Q, Rong L, He W, Liu SL, Liang C. 2011. The IFITM proteins inhibit HIV-1 infection. J Virol 85:2126-2137. http://dx.doi.org/10.1128/JVI.01531-10.
6. Everitt AR, Clare S, Pertel T, John SP, Wash RS, Smith SE, Chin CR, Feeley EM, Sims JS, Adams DJ, Wise HM, Kane L, Goulding D, Digard P, Anttila V, Baillie JK, Walsh TS, Hume DA, Palotie A, Xue Y, Colonna V, Tyler-Smith C, Dunning J, Gordon SB, Smyth RL, Openshaw PJ, Dougan G, Brass AL, Kellam P. 2012. IFITM3 restricts the morbidity and mortality associated with influenza. Nature 484:519-523. http://dx.doi.org/10.1038/nature10921.
7. Zhang YH, Zhao Y, Li N, Peng YC, Giannoulatou E, Jin RH, Yan HP, Wu H, Liu JH, Liu N, Wang DY, Shu YL, Ho LP, Kellam P, McMichael A, Dong T. 2013. Interferon-induced transmembrane protein-3 genetic variant rs12252-C is associated with severe influenza in Chinese individuals. Nat Commun 4:1418. http://dx.doi.org/10.1038/ncomms2433.
8. Feeley EM, Sims JS, John SP, Chin CR, Pertel T, Chen LM, Gaiha GD, Ryan BJ, Donis RO, Elledge SJ, Brass AL. 2011. IFITM3 inhibits influenza A virus infection by preventing cytosolic entry. PLoS Pathog 7:e1002337. http://dx.doi.org/10.1371/journal.ppat.1002337.
9. Li K, Markosyan RM, Zheng YM, Golfetto O, Bungart B, Li M, Ding S, He Y, Liang C, Lee JC, Gratton E, Cohen FS, Liu SL. 2013. IFITM proteins restrict viral membrane hemifusion. PLoS Pathog 9:e1003124. http://dx.doi.org/10.1371/journal.ppat.1003124.
10. Desai TM, Marin M, Chin CR, Savidis G, Brass AL, Melikyan GB. 2014. IFITM3 restricts influenza A virus entry by blocking the formation of fusion pores following virus-endosome hemifusion. PLoS Pathog 10: e1004048. http://dx.doi.org/10.1371/journal.ppat.1004048.
11. Amini-Bavil-Olyaee S, Choi YJ, Lee JH, Shi M, Huang IC, Farzan M, Jung JU. 2013. The antiviral effector IFITM3 disrupts intracellular cholesterol homeostasis to block viral entry. Cell Host Microbe 13:452-464. http://dx.doi.org/10.1016/j.chom.2013.03.006.
12. Yount JS, Moltedo B, Yang YY, Charron G, Moran TM, Lopez CB, Hang HC. 2010. Palmitoylome profiling reveals S-palmitoylationdependent antiviral activity of IFITM3. Nat Chem Biol 6:610-614. http://dx.doi.org/10.1038/nchembio.405.
13. John SP, Chin CR, Perreira JM, Feeley EM, Aker AM, Savidis G, Smith SE, Elia AE, Everitt AR, Vora M, Pertel T, Elledge SJ, Kellam P, Brass AL. 2013. TheCD225domain of IFITM3 is required for bothIFITMprotein association and inhibition of influenza A virus and dengue virus replication. J Virol 87: 7837-7852. http://dx.doi.org/10.1128/JVI.00481-13.
14. Yount JS, Karssemeijer RA, Hang HC. 2012. S-palmitoylation and ubiquitination differentially regulate interferon-induced transmembrane protein 3 (IFITM3)-mediated resistance to influenza virus. J Biol Chem 287: 19631-19641. http://dx.doi.org/10.1074/jbc.M112.362095.
15. Chesarino NM, McMichael TM, Hach JC, Yount JS. 2014. Phosphorylation of the antiviral protein IFITM3 dually regulates its endocytosis and ubiquitination. J Biol Chem 289:11986-11992. http://dx.doi.org/10.1074/jbc.M114.557694.
16. Jia R, Xu F, Qian J, Yao Y, Miao C, Zheng YM, Liu SL, Guo F, Geng Y, Qiao W, Liang C. 2014. Identification of an endocytic signal essential for the antiviral action of IFITM3. Cell Microbiol 16:1080-1093. http://dx.doi.org/10.1111/cmi.12262.
17. Friedman RL, Manly SP, McMahon M, Kerr IM, Stark GR. 1984. Transcriptional and posttranscriptional regulation of interferon-induced gene expression in human cells. Cell 38:745-755. http://dx.doi.org/10.1016/0092-8674(84)90270-8.
18. Miller LC, Jiang Z, Sang Y, Harhay GP, Lager KM. 2014. Evolutionary characterization of pig interferon-inducible transmembrane gene family and member expression dynamics in tracheobronchial lymph nodes of pigs infected with swine respiratory disease viruses. Vet Immunol Immunopathol 159:180-191. http://dx.doi.org/10.1016/j.vetimm.2014.02.015.
19. Ferrari M, Scalvini A, Losio MN, Corradi A, Soncini M, Bignotti E, Milanesi E, Ajmone-Marsan P, Barlati S, Bellotti D, Tonelli M. 2003. Establishment and characterization of two new pig cell lines for use in virological diagnostic laboratories. J Virol Methods 107:205-212. http://dx.doi.org/10.1016/S0166-0934(02)00236-7.
20. Sun E, He J, Zhuang X. 2013. Dissecting the role of COPI complexes on influenza virus infection. J Virol 87:2673-2685. http://dx.doi.org/10.1128/JVI.02277-12.
21. Hoffmann HH, Palese P, Shaw ML. 2008. Modulation of influenza virus replication by alteration of sodium ion transport and protein kinase C activity. Antiviral Res 80:124-134. http://dx.doi.org/10.1016/j.antiviral.2008.05.008.
22. Moncorge O, Long JS, Cauldwell AV, Zhou H, Lycett SJ, Barclay WS. 2013. Investigation of influenza virus polymerase activity in pig cells. J Virol 87:384-394. http://dx.doi.org/10.1128/JVI.01633-12.
23. Neumann G, Hobom G. 1995. Mutational analysis of influenza virus promoter elements in vivo. J Gen Virol 76:1709-1717. http://dx.doi.org/10.1099/0022-1317-76-7-1709.
24. Pfaffl MW. 2001. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29:e45.